Tandem Therapeutics
Tandem Therapeutics is developing first-in-class peptide therapeutics that target and treat the extracellular matrix barrier.
Visit websiteSwitzerland
Healthtech
Funding summary
- Total raised
- €152K
- Funding rounds
- 1
Investors in Tandem Therapeutics
Investors on record for Tandem Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Tandem Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors